2A Logo High-Res 296x264 Transparent

Exclusive worldwide license agreement

Medigene AG today announced that it has granted an exclusive, worldwide license for the development and commercialization of its preclinical stage adeno-associated virus-like particles (AAVLPs) technology to 2A Pharma AB.

Medigene 2A Pharma Press Release 2016-12-20